Between January @ and June @ , @ patients with advanced ( stage III or IV ) unresectable squamous cell carcinoma of the head and neck ( oral cavity , oropharynx , hypopharynx , and larynx ) were randomly assigned to two groups : one receiving two cycles of docetaxel , cisplatin , and @-fluorouracil ICT followed by CRT with three cycles of cisplatin and one treated by CRT alone .